Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ebos Group's share price for the quarter that ended in Dec. 2023 was $28.25. Ebos Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 192 Mil. Therefore, Ebos Group's market cap for the quarter that ended in Dec. 2023 was $5,419 Mil.
Ebos Group's quarterly market cap
increased
from Dec. 2022 ($4,006 Mil) to Jun. 2023 ($5,413 Mil) and
increased
from Jun. 2023 ($5,413 Mil) to Dec. 2023 ($5,419 Mil).
Ebos Group's annual market cap
increased
from Jun. 2021 ($3,450 Mil) to Jun. 2022 ($3,980 Mil) and
increased
from Jun. 2022 ($3,980 Mil) to Jun. 2023 ($5,413 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ebos Group's Enterprise Value for Today is $5,062 Mil.
Ebos Group Market Cap Historical Data
The historical data trend for Ebos Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Ebos Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group's Market Cap Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Ebos Group's Market Cap falls into.
Ebos Group Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Ebos Group's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (OTCPK:EBOSF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Ebos Group Market Cap Related Terms
Thank you for viewing the detailed overview of Ebos Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EBOSF has been successfully added to your 